CANCER RES 润色咨询

CANCER RESEARCH

出版年份：1941 年文章数：12632 投稿命中率： 开通期刊会员，数据随心看

出版周期：Semimonthly 自引率：2.6% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2269523, encodeId=636e226952300, content=一审意见基本是2-3周内返回，若需修改，1-2个月内完成。<br>若作者对一审意见有疑问，可礼貌地向编辑部提出申诉，但需注意，申诉过程可能延长审稿周期。<br>此外，期刊鼓励作者使用英文撰写，语言表达需准确流畅，必要时可请专业润色服务提升语言质量。<br>若作者希望加快出版速度，可选择开放获取（OA）模式，但需额外支付文章处理费（APC）2300美元。总体而言，《Cancer Research》是一本对高质量研究有较高要求的期刊，但其审稿效率和学术影响力使其成为许多肿瘤学研究者的首选目标。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722166, createdTime=Sun Jun 15 18:13:33 CST 2025, time=2025-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究<br>经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰<br>经验分享：能行吗 肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究<br>经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究<br>经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0<br>偏重的研究方向：肿瘤<br>经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省)]
    2025-06-15 ms6000002977722166 来自上海

    一审意见基本是2-3周内返回，若需修改，1-2个月内完成。
    若作者对一审意见有疑问，可礼貌地向编辑部提出申诉，但需注意，申诉过程可能延长审稿周期。
    此外，期刊鼓励作者使用英文撰写，语言表达需准确流畅，必要时可请专业润色服务提升语言质量。
    若作者希望加快出版速度，可选择开放获取（OA）模式，但需额外支付文章处理费（APC）2300美元。总体而言，《Cancer Research》是一本对高质量研究有较高要求的期刊，但其审稿效率和学术影响力使其成为许多肿瘤学研究者的首选目标。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2269523, encodeId=636e226952300, content=一审意见基本是2-3周内返回，若需修改，1-2个月内完成。<br>若作者对一审意见有疑问，可礼貌地向编辑部提出申诉，但需注意，申诉过程可能延长审稿周期。<br>此外，期刊鼓励作者使用英文撰写，语言表达需准确流畅，必要时可请专业润色服务提升语言质量。<br>若作者希望加快出版速度，可选择开放获取（OA）模式，但需额外支付文章处理费（APC）2300美元。总体而言，《Cancer Research》是一本对高质量研究有较高要求的期刊，但其审稿效率和学术影响力使其成为许多肿瘤学研究者的首选目标。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722166, createdTime=Sun Jun 15 18:13:33 CST 2025, time=2025-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究<br>经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰<br>经验分享：能行吗 肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究<br>经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究<br>经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0<br>偏重的研究方向：肿瘤<br>经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省)]
    2024-12-30 ms4000000265024223 来自山东省

    偏重的研究方向：肿瘤基础研究
    经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭

    8

    展开8条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2269523, encodeId=636e226952300, content=一审意见基本是2-3周内返回，若需修改，1-2个月内完成。<br>若作者对一审意见有疑问，可礼貌地向编辑部提出申诉，但需注意，申诉过程可能延长审稿周期。<br>此外，期刊鼓励作者使用英文撰写，语言表达需准确流畅，必要时可请专业润色服务提升语言质量。<br>若作者希望加快出版速度，可选择开放获取（OA）模式，但需额外支付文章处理费（APC）2300美元。总体而言，《Cancer Research》是一本对高质量研究有较高要求的期刊，但其审稿效率和学术影响力使其成为许多肿瘤学研究者的首选目标。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722166, createdTime=Sun Jun 15 18:13:33 CST 2025, time=2025-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究<br>经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰<br>经验分享：能行吗 肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究<br>经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究<br>经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0<br>偏重的研究方向：肿瘤<br>经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省)]
    2025-04-09 ms8000000289511534 来自四川省

    请问需要审稿费么？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2269523, encodeId=636e226952300, content=一审意见基本是2-3周内返回，若需修改，1-2个月内完成。<br>若作者对一审意见有疑问，可礼貌地向编辑部提出申诉，但需注意，申诉过程可能延长审稿周期。<br>此外，期刊鼓励作者使用英文撰写，语言表达需准确流畅，必要时可请专业润色服务提升语言质量。<br>若作者希望加快出版速度，可选择开放获取（OA）模式，但需额外支付文章处理费（APC）2300美元。总体而言，《Cancer Research》是一本对高质量研究有较高要求的期刊，但其审稿效率和学术影响力使其成为许多肿瘤学研究者的首选目标。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722166, createdTime=Sun Jun 15 18:13:33 CST 2025, time=2025-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究<br>经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰<br>经验分享：能行吗 肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究<br>经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究<br>经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0<br>偏重的研究方向：肿瘤<br>经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省)]
    2025-02-18 Mr.Never Die 来自上海

    偏重的研究方向：蛋白质翻译后修饰
    经验分享：能行吗 肿瘤的蛋白ptm 能中吗

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2269523, encodeId=636e226952300, content=一审意见基本是2-3周内返回，若需修改，1-2个月内完成。<br>若作者对一审意见有疑问，可礼貌地向编辑部提出申诉，但需注意，申诉过程可能延长审稿周期。<br>此外，期刊鼓励作者使用英文撰写，语言表达需准确流畅，必要时可请专业润色服务提升语言质量。<br>若作者希望加快出版速度，可选择开放获取（OA）模式，但需额外支付文章处理费（APC）2300美元。总体而言，《Cancer Research》是一本对高质量研究有较高要求的期刊，但其审稿效率和学术影响力使其成为许多肿瘤学研究者的首选目标。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722166, createdTime=Sun Jun 15 18:13:33 CST 2025, time=2025-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究<br>经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰<br>经验分享：能行吗 肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究<br>经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究<br>经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0<br>偏重的研究方向：肿瘤<br>经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省)]
    2025-01-16 dr_NEO 来自山东省

    偏重的研究方向：肿瘤基础研究
    经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2269523, encodeId=636e226952300, content=一审意见基本是2-3周内返回，若需修改，1-2个月内完成。<br>若作者对一审意见有疑问，可礼貌地向编辑部提出申诉，但需注意，申诉过程可能延长审稿周期。<br>此外，期刊鼓励作者使用英文撰写，语言表达需准确流畅，必要时可请专业润色服务提升语言质量。<br>若作者希望加快出版速度，可选择开放获取（OA）模式，但需额外支付文章处理费（APC）2300美元。总体而言，《Cancer Research》是一本对高质量研究有较高要求的期刊，但其审稿效率和学术影响力使其成为许多肿瘤学研究者的首选目标。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722166, createdTime=Sun Jun 15 18:13:33 CST 2025, time=2025-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究<br>经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰<br>经验分享：能行吗 肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究<br>经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究<br>经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0<br>偏重的研究方向：肿瘤<br>经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省)]
    2022-11-09 124af5c7m81暂无昵称

    请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？

    8

    展开8条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2269523, encodeId=636e226952300, content=一审意见基本是2-3周内返回，若需修改，1-2个月内完成。<br>若作者对一审意见有疑问，可礼貌地向编辑部提出申诉，但需注意，申诉过程可能延长审稿周期。<br>此外，期刊鼓励作者使用英文撰写，语言表达需准确流畅，必要时可请专业润色服务提升语言质量。<br>若作者希望加快出版速度，可选择开放获取（OA）模式，但需额外支付文章处理费（APC）2300美元。总体而言，《Cancer Research》是一本对高质量研究有较高要求的期刊，但其审稿效率和学术影响力使其成为许多肿瘤学研究者的首选目标。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722166, createdTime=Sun Jun 15 18:13:33 CST 2025, time=2025-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究<br>经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰<br>经验分享：能行吗 肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究<br>经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究<br>经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0<br>偏重的研究方向：肿瘤<br>经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省)]
    2024-04-28 147ce2ffm38(暂无昵称) 来自北京

    编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平

    10

    展开10条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2269523, encodeId=636e226952300, content=一审意见基本是2-3周内返回，若需修改，1-2个月内完成。<br>若作者对一审意见有疑问，可礼貌地向编辑部提出申诉，但需注意，申诉过程可能延长审稿周期。<br>此外，期刊鼓励作者使用英文撰写，语言表达需准确流畅，必要时可请专业润色服务提升语言质量。<br>若作者希望加快出版速度，可选择开放获取（OA）模式，但需额外支付文章处理费（APC）2300美元。总体而言，《Cancer Research》是一本对高质量研究有较高要求的期刊，但其审稿效率和学术影响力使其成为许多肿瘤学研究者的首选目标。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722166, createdTime=Sun Jun 15 18:13:33 CST 2025, time=2025-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究<br>经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰<br>经验分享：能行吗 肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究<br>经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究<br>经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0<br>偏重的研究方向：肿瘤<br>经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省)]
    2024-08-16 ms3000001981169340 来自上海

    偏重的研究方向：肿瘤研究
    经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2269523, encodeId=636e226952300, content=一审意见基本是2-3周内返回，若需修改，1-2个月内完成。<br>若作者对一审意见有疑问，可礼貌地向编辑部提出申诉，但需注意，申诉过程可能延长审稿周期。<br>此外，期刊鼓励作者使用英文撰写，语言表达需准确流畅，必要时可请专业润色服务提升语言质量。<br>若作者希望加快出版速度，可选择开放获取（OA）模式，但需额外支付文章处理费（APC）2300美元。总体而言，《Cancer Research》是一本对高质量研究有较高要求的期刊，但其审稿效率和学术影响力使其成为许多肿瘤学研究者的首选目标。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722166, createdTime=Sun Jun 15 18:13:33 CST 2025, time=2025-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究<br>经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰<br>经验分享：能行吗 肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究<br>经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究<br>经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0<br>偏重的研究方向：肿瘤<br>经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省)]
    2023-09-21 ms1000000959787142 来自天津

    各位大佬们，这个杂志under editorial consideration 大概需要多久呀

    8

    展开8条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2269523, encodeId=636e226952300, content=一审意见基本是2-3周内返回，若需修改，1-2个月内完成。<br>若作者对一审意见有疑问，可礼貌地向编辑部提出申诉，但需注意，申诉过程可能延长审稿周期。<br>此外，期刊鼓励作者使用英文撰写，语言表达需准确流畅，必要时可请专业润色服务提升语言质量。<br>若作者希望加快出版速度，可选择开放获取（OA）模式，但需额外支付文章处理费（APC）2300美元。总体而言，《Cancer Research》是一本对高质量研究有较高要求的期刊，但其审稿效率和学术影响力使其成为许多肿瘤学研究者的首选目标。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722166, createdTime=Sun Jun 15 18:13:33 CST 2025, time=2025-06-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2245612, encodeId=e68a2245612be, content=偏重的研究方向：肿瘤基础研究<br>经验分享：请问最近cancer research的编辑还在过节吗？快十天了还没做决定😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d5e8174870, createdName=ms4000000265024223, createdTime=Mon Dec 30 16:33:58 CST 2024, time=2024-12-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2259727, encodeId=f4cd2259e2747, content=请问需要审稿费么？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Wed Apr 09 13:36:34 CST 2025, time=2025-04-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252518, encodeId=0fc92252518a1, content=偏重的研究方向：蛋白质翻译后修饰<br>经验分享：能行吗 肿瘤的蛋白ptm 能中吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Tue Feb 18 17:00:53 CST 2025, time=2025-02-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248334, encodeId=9fd82248334a4, content=偏重的研究方向：肿瘤基础研究<br>经验分享：收到external peer review邮件42天系统状态还是under review这正常吗😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Thu Jan 16 14:18:09 CST 2025, time=2025-01-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究<br>经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0<br>偏重的研究方向：肿瘤<br>经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省)]
    2023-06-18 ms2000000311873048 来自湖南省

    审稿速度:1.0
    偏重的研究方向：肿瘤
    经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧

    3

    展开3条回复
共415条页码: 1/42页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分